Hoai X Nguyen1,2, Edgar A O'Rear3,4. 1. School of Chemical, Biological and Materials Engineering, University of Oklahoma, 100 E. Boyd, SEC, T301, Norman, Oklahoma, 73019, USA. 2. University of Oklahoma Biomedical Engineering Center, Norman, Oklahoma, 73019, USA. 3. School of Chemical, Biological and Materials Engineering, University of Oklahoma, 100 E. Boyd, SEC, T301, Norman, Oklahoma, 73019, USA. eorear@ou.edu. 4. University of Oklahoma Biomedical Engineering Center, Norman, Oklahoma, 73019, USA. eorear@ou.edu.
Abstract
PURPOSE: To test the hypothesis that a mixture combining fast and slower release rate microspheres can restore blood flow rapidly and prevent formation of another blockage in thrombolysis. METHODS: We used polyethylene glycol (PEG) microspheres which provide the release of the encapsulated streptokinase (SK) on the scale of minutes, and Eudragit FS30D (Eud), a polymethacrylate polymer, for development of delayed release microspheres which were desirable to prevent a putative second thrombus. Eud microspheres were coated with chitosan (CS) to further extend half-life. Experiments included the development, characterization of Eud/SK and CS-Eud/SK microspheres, and in vitro thrombolytic studies of the mixtures of PEG/SK and Eud /SK microspheres and of PEG/SK and CS-Eud/SK microspheres. RESULTS: CS-Eud/SK microspheres have slightly lower encapsulation efficiency, reduced activity of SK, and a much slower release of SK when compared with microspheres of Eud/SK microspheres. Counter-intuitively, slower release leads to faster thrombolysis after reocclusion as a result of greater retention of agent and the mechanism of distributed intraclot thrombolysis. CONCLUSIONS: A mixture of PEG/SK and CS-Eud/SK microspheres could break up the blood clot rapidly while providing clot-lytic efficacy in prevention of a second blockage up to 4 h.
PURPOSE: To test the hypothesis that a mixture combining fast and slower release rate microspheres can restore blood flow rapidly and prevent formation of another blockage in thrombolysis. METHODS: We used polyethylene glycol (PEG) microspheres which provide the release of the encapsulated streptokinase (SK) on the scale of minutes, and Eudragit FS30D (Eud), a polymethacrylate polymer, for development of delayed release microspheres which were desirable to prevent a putative second thrombus. Eud microspheres were coated with chitosan (CS) to further extend half-life. Experiments included the development, characterization of Eud/SK and CS-Eud/SK microspheres, and in vitro thrombolytic studies of the mixtures of PEG/SK and Eud /SK microspheres and of PEG/SK and CS-Eud/SK microspheres. RESULTS:CS-Eud/SK microspheres have slightly lower encapsulation efficiency, reduced activity of SK, and a much slower release of SK when compared with microspheres of Eud/SK microspheres. Counter-intuitively, slower release leads to faster thrombolysis after reocclusion as a result of greater retention of agent and the mechanism of distributed intraclot thrombolysis. CONCLUSIONS: A mixture of PEG/SK and CS-Eud/SK microspheres could break up the blood clot rapidly while providing clot-lytic efficacy in prevention of a second blockage up to 4 h.
Authors: Kateřina Dvořáčková; Miloslava Rabišková; Jan Muselík; Jan Gajdziok; Martina Bajerová Journal: Drug Dev Ind Pharm Date: 2011-03-21 Impact factor: 3.225
Authors: Clinton F Jones; Robert A Campbell; Zechariah Franks; Christopher C Gibson; Giridhar Thiagarajan; Adriana Vieira-de-Abreu; Sivaprasad Sukavaneshvar; S Fazal Mohammad; Dean Y Li; Hamidreza Ghandehari; Andrew S Weyrich; Benjamin D Brooks; David W Grainger Journal: Mol Pharm Date: 2012-05-04 Impact factor: 4.939
Authors: Denise A B Smith; Sampada S Vaidya; Jonathan A Kopechek; Shao-Ling Huang; Melvin E Klegerman; David D McPherson; Christy K Holland Journal: Ultrasound Med Biol Date: 2010-01 Impact factor: 2.998